Risk estimation of metabolic syndrome at one and three years after a pregnancy complicated by preeclampsia.

[1]  S. Wen,et al.  Ten-year, thirty-year, and lifetime cardiovascular disease risk estimates following a pregnancy complicated by preeclampsia. , 2012, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[2]  Rowena J Dolor,et al.  Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association. , 2011, Journal of the American College of Cardiology.

[3]  Faha,et al.  Aha Guideline Effectiveness-based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update a Guideline from the American Heart Association Executive Writing Committee Expert Panel Members Cvd Risk Assessment Table 1. Class Iii Interventions (not Useful/effective and May Be Harmfu , 2022 .

[4]  B. Zinman,et al.  Glucose intolerance in pregnancy and postpartum risk of metabolic syndrome in young women. , 2010, The Journal of clinical endocrinology and metabolism.

[5]  R. Retnakaran.  Glucose tolerance status in pregnancy: a window to the future risk of diabetes and cardiovascular disease in young women. , 2009, Current diabetes reviews.

[6]  B. Shah,et al.  Mild glucose intolerance in pregnancy and risk of cardiovascular disease: a population-based cohort study , 2009, Canadian Medical Association Journal.

[7]  Tezeta F. Mitiku,et al.  Trends in risk factors for cardiovascular disease in Canada: temporal, socio-demographic and geographic factors , 2009, Canadian Medical Association Journal.

[8]  G. Koren,et al.  Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women , 2009, Canadian Medical Association Journal.

[9]  Graeme N. Smith.  Development of preeclampsia provides a window of opportunity for early cardiovascular risk screening and intervention , 2009 .

[10]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[11]  S. Wen,et al.  A history of preeclampsia identifies women who have underlying cardiovascular risk factors. , 2009, American journal of obstetrics and gynecology.

[12]  K. Tu,et al.  Prevalence and incidence of hypertension from 1995 to 2005: a population-based study , 2008, Canadian Medical Association Journal.

[13]  S. Grundy,et al.  Association Conference on Scientific Issues Related to Management Association/National Heart, Lung, and Blood Institute/American Diabetes Clinical Management of Metabolic Syndrome : Report of the American Heart , 2008 .

[14]  D. Lloyd‐Jones.  Short-term versus long-term risk for coronary artery disease: implications for lipid guidelines , 2006, Current opinion in lipidology.

[15]  M. Schull,et al.  Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study , 2005, The Lancet.

[16]  H. Gammill,et al.  Pre-eclampsia and cardiovascular disease in later life , 2005, The Lancet.

[17]  Richard Kahn,et al.  The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. , 2005, Diabetes care.

[18]  D. Malaspina,et al.  Risk factors for pre-eclampsia in nulliparous and parous women: the Jerusalem perinatal study. , 2005, Paediatric and perinatal epidemiology.

[19]  S. Grundy,et al.  Clinical Management of Metabolic Syndrome: Report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association Conference on Scientific Issues Related to Management , 2004, Circulation.

[20]  Claude Lenfant,et al.  Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[21]  R. T. Lie,et al.  Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. , 2001, BMJ : British Medical Journal.

[22]  J. Pell,et al.  Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129 290 births , 2001, The Lancet.

[23]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[24]  P. Gruenwald.  Developmental pathology; a new field in medicine. , 1949, American journal of obstetrics and gynecology.